Single-use negative pressure wound therapy for the treatment of chronic lower leg wounds

2015 ◽  
Vol 24 (Sup2) ◽  
pp. S4-S9 ◽  
Author(s):  
J.A. Schwartz ◽  
S.G. Goss ◽  
F. Facchin ◽  
C. Gendics ◽  
J.C. Lantis
Author(s):  
Shi-Ying Jin ◽  
Mei Chen ◽  
Feng-Yuan Wang ◽  
Fei Wang

Pyoderma gangrenosum (PG) is a rare chronic neutrophilic dermatosis that causes undermining ulcers. Unfortunately, standardization of PG treatment remains a challenge. In this article, we describe a case in which a 69-year-old man presented with a painful ulcer on the right lower leg. The diagnosis of PG was made after excluding other diseases. He had a history of PG on his left lower leg 2 years earlier and was cured by the treatment of systemic corticosteroids and cyclosporin A for 43 days. However, such a treatment was not effective this time. Hence, we applied intravenous immunoglobulin and negative-pressure wound therapy, and the patient was cured. Altogether, this case supports the use of intravenous immunoglobulin as an effective adjuvant for refractory PG, and indicates negative-pressure wound therapy as a treatment option to advance ulcer healing under adequate immunosuppression.


Author(s):  
Varuni R. Brownhill ◽  
Elizabeth Huddleston ◽  
Andrea Bell ◽  
Jeffrey Hart ◽  
Iain Webster ◽  
...  

2021 ◽  
Vol 30 (9) ◽  
pp. 705-710
Author(s):  
Marald Wikkeling ◽  
Judith Mans ◽  
Timothy Styche

Objective: Surgical site complications (SSCs) such as dehiscence and infection are a common issue within vascular surgeries and are a key concern to payers and clinicians. It is estimated that occurrence of complications in vascular surgery can increment length of stay by 9.72 days and costs by £3776 per episode. The objective of this research was to determine the clinical and economic impact of the prophylactic use of single use negative pressure wound therapy (sNWPT) in postoperative femoral endarterectomy incisions within a single centre in the Netherlands. Method: Data were extracted retrospectively from the medical notes of patients consecutively treated for femoral endarterectomy between January 2013 and December 2019 in a single centre in the Netherlands. Since August 2016, patients were treated with the sNPWT device and their data were compared with that of patients treated before the introduction of the device. Data were extracted on SSCs and associated healthcare resource use, with comparisons made between the two patient groups. Results: The study included a cohort of 108 patients. Data of patients treated by standard care (n=64) showed 32 (50%) patients developed complications. This reduced significantly in patients treated with the sNPWT device (n=44) of whom eight (18.2%) developed a postoperative complication (p=0.0011). Average postoperative costs per patient were €3119 for those in the standard care group and €2630 where the sNPWT device was used. Conclusion: sNPWT provided clinical and economic benefits over standard care in the treatment of femoral endarterectomy patients, significantly reducing rate of complication and their associated costs.


2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Miguel León Arellano ◽  
Cristina Barragán Serrano ◽  
Manuela Guedea ◽  
Juan Carlos Garcia Pérez ◽  
Gonzalo Sanz Ortega ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document